Aurinia Pharmaceuticals Inc.
AUPH
$14.07
-$0.01-0.07%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 397.94M | 351.51M | 315.05M | 312.59M | 358.44M |
| Total Receivables | 42.15M | 30.93M | 40.39M | 40.55M | 37.14M |
| Inventory | 45.69M | 44.79M | 46.50M | 46.20M | 39.23M |
| Prepaid Expenses | 5.75M | 11.11M | 6.58M | 5.54M | 11.22M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 433.00K | 401.00K | 453.00K | 896.00K | 566.00K |
| Total Current Assets | 491.97M | 438.74M | 408.97M | 405.76M | 446.60M |
|
|
|||||
| Total Current Assets | 491.97M | 438.74M | 408.97M | 405.76M | 446.60M |
| Net Property, Plant & Equipment | 79.57M | 84.80M | 89.45M | 94.11M | 98.87M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 3.76M | 3.90M | 4.05M | 4.16M | 4.36M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 176.29M | 93.00K | 93.00K | 823.00K | 823.00K |
| Total Assets | 751.59M | 527.53M | 502.56M | 504.85M | 550.65M |
|
|
|||||
| Total Accounts Payable | 3.31M | 2.21M | 3.31M | 4.22M | 5.19M |
| Total Accrued Expenses | 66.47M | 49.32M | 49.39M | 41.73M | 54.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.59M | 17.37M | 17.21M | 15.54M | 15.07M |
| Total Finance Division Other Current Liabilities | 6.35M | 7.32M | 8.35M | 6.91M | 23.39M |
| Total Other Current Liabilities | 6.35M | 7.32M | 8.35M | 6.91M | 23.39M |
| Total Current Liabilities | 93.72M | 76.22M | 78.27M | 68.41M | 97.76M |
|
|
|||||
| Total Current Liabilities | 93.72M | 76.22M | 78.27M | 68.41M | 97.76M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 57.22M | 60.85M | 64.62M | 62.37M | 64.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 19.31M | 24.69M | 24.38M | 23.89M | 11.11M |
| Total Liabilities | 170.26M | 161.76M | 167.26M | 154.66M | 173.17M |
|
|
|||||
| Common Stock & APIC | 1.23B | 1.23B | 1.23B | 1.26B | 1.31B |
| Retained Earnings | -649.37M | -860.16M | -891.71M | -913.23M | -936.57M |
| Treasury Stock & Other | -599.00K | -749.00K | -905.00K | -825.00K | -647.00K |
| Total Common Equity | 581.33M | 365.77M | 335.30M | 350.19M | 377.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 581.33M | 365.77M | 335.30M | 350.19M | 377.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 581.33M | 365.77M | 335.30M | 350.19M | 377.48M |
|
|
|||||